8.05
0.25%
-0.02
After Hours:
8.00
-0.05
-0.62%
Guardion Health Sciences Inc stock is currently priced at $8.05, with a 24-hour trading volume of 4,092.
It has seen a -0.25% decreased in the last 24 hours and a -9.75% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $8.00 pivot point. If it approaches the $8.14 resistance level, significant changes may occur.
Guardion Health Sciences Inc Stock (GHSI) Financials Data
Guardion Health Sciences Inc (GHSI) Revenue 2024
GHSI reported a revenue (TTM) of $12.25 million for the quarter ending December 31, 2023, a +10.85% rise year-over-year.
Guardion Health Sciences Inc (GHSI) Net Income 2024
GHSI net income (TTM) was $158.00 thousand for the quarter ending December 31, 2023, a +101.06% increase year-over-year.
Guardion Health Sciences Inc (GHSI) Cash Flow 2024
GHSI recorded a free cash flow (TTM) of -$4.37 million for the quarter ending December 31, 2023, a +41.31% increase year-over-year.
Guardion Health Sciences Inc (GHSI) Earnings per Share 2024
GHSI earnings per share (TTM) was $0.11 for the quarter ending December 31, 2023, a +100.67% growth year-over-year.
Guardion Health Sciences Inc Stock (GHSI) Latest News
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Benzinga
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
GlobeNewswire Inc.
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.
GlobeNewswire Inc.
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
GlobeNewswire Inc.
About Guardion Health Sciences Inc
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.
Cap:
|
Volume (24h):